Davita Inc (NYSE:DVA) saw some unusual options trading activity on Wednesday. Investors purchased 2,058 call options on the stock. This is an increase of approximately 1,104% compared to the typical volume of 171 call options.
Shares of Davita stock opened at $66.84 on Thursday. The firm has a market cap of $12,079.34, a PE ratio of 19.43, a P/E/G ratio of 0.96 and a beta of 1.03. Davita has a 1-year low of $52.51 and a 1-year high of $80.71. The company has a debt-to-equity ratio of 1.87, a current ratio of 2.88 and a quick ratio of 2.82.
Davita (NYSE:DVA) last posted its quarterly earnings data on Tuesday, February 13th. The company reported $0.92 earnings per share for the quarter, missing the consensus estimate of $0.94 by ($0.02). Davita had a return on equity of 12.86% and a net margin of 4.65%. The company had revenue of $2.78 billion during the quarter, compared to analyst estimates of $3.90 billion. During the same period in the previous year, the company earned $0.98 EPS. analysts forecast that Davita will post 4.15 EPS for the current fiscal year.
Several equities analysts have recently issued reports on DVA shares. Raymond James Financial raised shares of Davita from an “outperform” rating to a “strong-buy” rating and boosted their price target for the company from $65.00 to $84.00 in a report on Thursday, December 7th. Bank of America raised shares of Davita from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $75.00 to $85.00 in a report on Thursday, January 4th. Citigroup raised shares of Davita from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $67.71 to $82.00 in a report on Monday, December 11th. SunTrust Banks set a $75.00 price objective on shares of Davita and gave the stock a “hold” rating in a report on Thursday, December 21st. Finally, Zacks Investment Research raised shares of Davita from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 2nd. Two investment analysts have rated the stock with a sell rating, five have given a hold rating, four have assigned a buy rating and two have issued a strong buy rating to the stock. Davita presently has an average rating of “Hold” and a consensus target price of $79.30.
In other news, insider James K. Hilger sold 3,572 shares of the business’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $78.95, for a total transaction of $282,009.40. Following the completion of the transaction, the insider now owns 33,649 shares of the company’s stock, valued at $2,656,588.55. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 2.00% of the company’s stock.
A number of institutional investors have recently modified their holdings of the business. Millennium Management LLC raised its position in Davita by 239.9% in the fourth quarter. Millennium Management LLC now owns 2,024,308 shares of the company’s stock worth $146,256,000 after acquiring an additional 1,428,810 shares in the last quarter. OppenheimerFunds Inc. raised its position in Davita by 5,292.6% in the fourth quarter. OppenheimerFunds Inc. now owns 1,873,918 shares of the company’s stock worth $135,391,000 after acquiring an additional 1,839,168 shares in the last quarter. Geode Capital Management LLC raised its position in Davita by 1.0% in the fourth quarter. Geode Capital Management LLC now owns 1,609,652 shares of the company’s stock worth $116,051,000 after acquiring an additional 16,017 shares in the last quarter. Bridger Management LLC bought a new stake in Davita in the fourth quarter worth about $52,339,000. Finally, First Trust Advisors LP raised its position in Davita by 5.1% in the fourth quarter. First Trust Advisors LP now owns 650,039 shares of the company’s stock worth $46,965,000 after acquiring an additional 31,743 shares in the last quarter. Hedge funds and other institutional investors own 85.79% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Traders Buy Large Volume of Call Options on Davita (DVA)” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international copyright legislation. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2018/03/22/traders-buy-large-volume-of-call-options-on-davita-dva.html.
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.